TickerFacts.

Profusa, Inc. (PFSA): R&D Expense

Annual figures by period end, from SEC filings.

$2.80M
Year ended 2025-12-31
$3.95M
Trailing 12 months to 2026-06-30
2024-12-31: $1.61M2025-12-31: $2.80M$2.80M
2024-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$2.80M+74.4%2026-04-15, From 2025-01-01
2024-12-31$1.61Mn/a2026-04-15, From 2024-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Profusa, Inc. (PFSA)2025-12-31$2.80M+74.4%
PetVivo Holdings, Inc. (PETV)2026-03-31$1.42M-10.6%
Harvard Apparatus Regenerative Technology, Inc. (HRGN)2025-12-31$2.65M+14.8%
QTREX Quantum Ltd. (QTEX)2025-12-31$7.50M+18.6%
HeartBeam, Inc. (BEATW)2025-12-31$13.45M+21.7%
Aethlon Medical Inc (AEMD)2026-03-31$1.91M-13.6%
Biotricity Inc. (BTCY)2026-03-31$2.76M+28.2%
QHSLab, Inc. (USAQ)2025-12-31$484.9K+64.7%
Medinotec Inc. (MDNC)2026-02-28$149.9K+64.4%

Compare PFSA, PETV, HRGN, QTEX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗